Nanochon Email Format
Biotechnology ResearchDistrict of Columbia, United States11-50 Employees
Nanochon is a Washington, District of Columbia–based biotechnology research company focused on developing regenerative joint solutions. It is pursuing an implant designed to replace damaged cartilage while promoting new tissue growth, using 3D printing and a novel material. The device is intended to function as both a load-bearing orthopedic implant and a scaffold for tissue regeneration, with the goal of faster recoveries and potential cost benefits for providers and patients. Its target market includes younger patients experiencing cartilage damage or early-stage loss from injury, for whom traditional joint replacement is invasive and less suitable. Nanochon has gained industry recognition, including being named as an awardee in Johnson & Johnson Innovation's Innovations for Vets QuickFire Challenge.